We examined validators of MCI diagnosis: baseline hippocampal volume and entorhinal cortex thickness; baseline CSF Aβ1–42, tau and phosphorylated tau (p-tau); change in hippocampal volume and entorhinal cortex volume over time; and progression to AD. The gene discussed is MAPT; the disease is Alzheimer disease.